. 2021 Jul;60(4):475–483. doi: 10.30802/AALAS-JAALAS-20-000103

Table 3.

Posterior means of proportional reduction in FEC compared with untreated animals and the probability of shedding for each treatment group, with associated lower and upper bounds of the 95% CI (LCB and UCB, respectively)

Group	No. of animals	Mean	LCB	UCB	P ^c
Proportional reduction in FEC
Fenbendazole	16	0.04	0.01	0.14^a	0.0001^a
Ivermectin	16	0.07	0.02	0.18^a	0.00006^a
Fenbendazole+ivermectin	15	0.12	0.02	0.40^a	0.0018^a
Control	18	1^b	NA	NA	NA
Probability of shedding
Fenbendazole	16	0.21	0.06	0.43^a	<0.00001^a
Ivermectin	16	0.40	0.20	0.61^a	<0.00001^a
Fenbendazole+ivermectin	15	0.07	0.01	0.19^a	<0.00001^a
Control	18	0.93	0.85	0.98	NA

NA, not applicable.

^{^a}

Value for treatment group is significantly different than that for the control group.

^{^b}

Proportional reduction in FEC is defined as 1 because proportion is calculated relative to the control group.

^{^c}

P values indicate the probability that each treatment did not reduce FEC or shedding probability according to the posterior distribution of each treatment effect.